Little movement for London stocks as gains in pharma offset by other sectors

London stocks tread water as pharma gains negated by drops in chemicals and insurers.

Mark Rogers

Mark Rogers

London stocks were largely unchanged on Friday as advances in pharmaceutical and biotechnology companies were counterbalanced by declines in chemicals and life insurance firms while rising bond yields further pressured market sentiment.

The FTSE 100 was flat by 10:15 GMT, with the FTSE 250 rising 0.4%. Both indexes are poised for a second straight weekly drop.

The yield on the 10-year UK government bond climbed to its highest level since December, weighing on equities. Shares of Legal & General fell 2.8%, leading to a 1.6% decline in life insurers after Citigroup cut its price target on the stock.

Article Continues Below Advertisement

Read More News:
Gold holds steady as markets await inflation data

Meanwhile, the chemicals sector dropped 1.4% as speciality chemicals company Victrex saw a 1.9% share price fall following a revenue decline last quarter.

On the upside, pharma and biotech stocks rose 0.9%, recovering some of the previous session’s over 4% slide triggered by disappointing earnings from AstraZeneca.

In corporate developments, Tesco announced it is selling most of its banking unit to Barclays for £600 million. Tesco shares rose 0.8% while Barclays dipped 1.3%.

In small caps, motor finance provider S&U was the worst performer on the plunging 7.8%, after its annual profit forecast fell short of market projections.

Don't Miss Out

Stay ahead with our latest news and analysis. Get the latest content directly to your inbox in one easy step.

Compare Investing Platforms

eToro

Winner of #1 Investor Community award by StockBrokers. Your capital is at risk.

Learn More
AJ Bell

Buy from 2000+ Funds & Shares in a low-cost tax-free ISA. Your capital is at risk.

Learn More